层粘连蛋白病患者心脏移植后心脏及心外结局
本研究回顾性分析法国三中心2003至2024年40例因LMNA基因相关扩张型心肌病接受心脏移植的患者,并与160例倾向评分匹配的非缺血性扩张型心肌病移植患者比较。结果显示移植后生存率与匹配组相当,但移植前发生电风暴与死亡率独立相关,而神经肌肉受累与死亡率无关且移植后未恶化。
要点
- 层粘连蛋白病患者心脏移植后1年生存率74%,5年70%,与匹配扩张型心肌病移植患者相当。
- 移植前数日内发生电风暴是唯一与死亡率相关的因素(HR 8.46)。
- 神经肌肉和心外受累与死亡率无关,且移植后未加重,不应视为移植禁忌。
核心结论
- 层粘连蛋白病患者心脏移植后生存率与匹配的非缺血性扩张型心肌病移植患者相当。
- 移植前电风暴发生与死亡率独立相关,而神经肌肉受累与死亡率无关且移植后未恶化。
研究设计与样本
- 回顾性研究,纳入2003至2024年法国三中心连续接受心脏移植的层粘连蛋白病患者40例。
- 采用倾向评分匹配,与160例匹配的非缺血性扩张型心肌病心脏移植患者比较。
主要发现
- 层粘连蛋白病组中位年龄45.4岁,男性占57.5%,33%的患者因电风暴接受移植。
- 移植后3个月、1年、5年生存率分别为90%、74%、70%,与匹配扩张型心肌病组比较HR 1.01(95%CI 0.52-1.95,p=0.98)。
- 移植前数日内发生电风暴与死亡率相关,HR 8.46(95%CI 1.66-43.17,p=0.002)。
- 神经肌肉和心外受累与死亡率无关,且移植后未加重。
临床怎么用
- 对于层粘连蛋白病患者,应考虑早期心脏移植,尤其在出现心律失常不稳定时。
- 轻度神经肌肉受累不应视为心脏移植的禁忌证。
局限性
- 回顾性研究设计,样本量较小(层粘连蛋白病组40例)。
- 仅纳入法国三个中心,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: LMNA gene-related dilated cardiomyopathy (DCM), or laminopathy, leads to severe heart failure, neuromuscular involvement and ventricular arrhythmia and has been described as the most frequent DCM genetic cause requiring heart transplantation (HTx). However, no study has specifically evaluated outcomes of HTx in patients with laminopathy. We aimed to describe and evaluate the clinical outcomes of this specific population. METHODS: Data from all consecutive patients with laminopathy who underwent HTx (LMNA-HTx) between 2003 and 2024 in three French centres were retrospectively extracted. Patients in the LMNA-HTx group were compared with patients with matched non-ischaemic DCM who underwent HTx (DCM-HTx) using propensity score matching. The primary endpoints were 1 year and long-term post-HTx survival. Secondary objectives were to describe mortality risk factors and assess the progression and impact of neuromuscular symptoms after HTx. RESULTS: 40 patients with laminopathy underwent HTx (median age 45.4 years, 57.5% males). HTx followed electrical storm (ES) in 33% of cases. Post-HTx survival at 3 months, 1 year and 5 years was 90%, 74% and 70%, respectively, comparable to 160 matched patients in the DCM-HTx group (Kaplan-Meier survival analysis: HR: 1.01; 95% CI 0.52 to 1.95; p=0.98). The occurrence of ES in the days preceding HTx emerged as the only factor associated with mortality (Kaplan-Meier survival analysis: HR: 8.46; 95% CI 1.66 to 43.17; p=0.002). Neuromuscular and extracardiac involvement was not associated with mortality and did not worsen after HTx. CONCLUSIONS: In this first systematic evaluation of HTx in patients with laminopathy, we show that post-transplant survival was comparable between LMNA-HTx and matched DCM-HTx patients and was not associated with neuromuscular involvement. In contrast, ES occurred in one-third of patients prior to HTx and was associated with mortality. These findings support considering HTx early in the disease course, particularly in the setting of arrhythmogenic instability, while mild neuromuscular involvement should not be viewed as a contraindication.
引用
- Giordano G, Coutance G, Wahbi K, et al. Cardiac and extracardiac outcomes after heart transplantation in laminopathies. Heart. 2026. PMID: 42336625. doi:10.1136/heartjnl-2026-327844
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。